Literature DB >> 9498969

Ventricular arrhythmias in adult aortic stenosis: prevalence, mechanisms, and clinical relevance.

A Sorgato1, P Faggiano, G P Aurigemma, C Rusconi, W H Gaasch.   

Abstract

With the longer life expectancy of the population, calcific aortic stenosis has become a common cardiac problem in the elderly. When patients with moderate to severe aortic stenosis become symptomatic, the prognosis is usually poor in absence of valve replacement and sudden death is a feared complication. It has been hypothesized that malignant ventricular arrhythmias could be responsible for the high incidence of sudden death in symptomatic patients with aortic stenosis. The purpose of this review is to analyze the prevalence, the electrophysiologic mechanisms, and the possible role of ventricular arrhythmias in the development of symptoms and in the outcome of adult subjects with aortic stenosis.

Entities:  

Mesh:

Year:  1998        PMID: 9498969     DOI: 10.1378/chest.113.2.482

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Predictors of syncope in patients with severe aortic stenosis: The role of orthostatic unload test.

Authors:  Paweł Kleczyński; Paweł Petkow Dimitrow; Artur Dziewierz; Agata Wiktorowicz; Tomasz Rakowski; Andrzej Surdacki; Dariusz Dudek
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

Review 2.  Management of tachyarrhythmias in pregnancy - A review.

Authors:  Priyanka Kugamoorthy; Danna A Spears
Journal:  Obstet Med       Date:  2020-04-20

3.  Recurrent ventricular tachycardia managed with balloon aortic valvuloplasty: an unusual presentation of severe aortic stenosis.

Authors:  Peace Tamuno; Rajesh Nair; Chris Nunn; Gerard Devlin
Journal:  BMJ Case Rep       Date:  2014-10-15

4.  Torsades de pointes as a cause of sudden death in a patient with aortic stenosis and atrial fibrillation.

Authors:  Polychronis Dilaveris; Charalambos Vassilopoulos; Evaggelia Tsagga; Manolis Vavuranakis; Christodoulos Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-07       Impact factor: 1.468

Review 5.  Exercise related syncope, when it's not the heart.

Authors:  C T Paul Krediet; Arthur A M Wilde; Wouter Wieling; John R Halliwill
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

6.  Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis.

Authors:  Zisis Dimitriadis; Marcus Wiemer; Werner Scholtz; Lothar Faber; Cornelia Piper; Thomas Bitter; Ippokratis Messaritakis; Kevin Bullert; Jochen Boergermann; Georg Kleikamp; Christian Prinz; Dieter Horstkotte; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2013-08-21       Impact factor: 5.460

7.  Evaluation of Tp-E Interval and Tp-E/QT Ratio in Patients with Aortic Stenosis.

Authors:  Çağrı Yayla; Murat Bilgin; Mehmet Kadri Akboğa; Kadriye Gayretli Yayla; Uğur Canpolat; Lale Dinç Asarcikli; Mehmet Doğan; Osman Turak; Serkan Çay; Özcan Özeke; Ahmet Akyel; Ekrem Yeter; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-08-05       Impact factor: 1.468

Review 8.  The contemporary role of echocardiography in the assessment and management of aortic stenosis.

Authors:  Takeshi Kitai; Rayji S Tsutsui
Journal:  J Med Ultrason (2001)       Date:  2019-12-02       Impact factor: 1.314

9.  The effect of transcatheter aortic valve implantation on Tp-e interval, Tp-e/QT and Tp-e/QTc ratios, and Tp-e dispersion in patients with severe aortic stenosis.

Authors:  Zülkif Tanrıverdi; Tuğçe Çöllüoğlu; Barış Ünal; Hüseyin Dursun; Dayimi Kaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

10.  Effect of transcatheter aortic valve implantation on QT dispersion in patients with aortic stenosis.

Authors:  Hakan Erkan; Engin Hatem; Mustafa Tarık Ağaç; Levent Korkmaz; Teyyar Gökdeniz; Ahmet Çağrı Aykan; Ezgi Kalaycıoğlu; Faruk Boyacı; Ömer Faruk Çırakoğlu; Şükrü Çelik
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.